Citigroup Inc Finch Therapeutics Group, Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.91 - $5.11 $521 - $1,395	-273 Reduced 84.78%	49 $0
Q1 2022 May 12, 2022	SELL	$5.02 - $10.47 $7,806 - $16,280	-1,555 Reduced 82.84%	322 $2,000
Q4 2021 Feb 10, 2022	BUY	$8.95 - $16.88 $8,905 - $16,795	995 Added 112.81%	1,877 $19,000
Q3 2021 Nov 10, 2021	BUY	$12.2 - $16.75 $10,760 - $14,773	882 New	882 $11,000

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $63.4M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.